Results 181 to 190 of about 193,733 (306)
CLDN18.2 antibody design with protein language models: A deep learning optimization framework. [PDF]
Qu T +8 more
europepmc +1 more source
ABSTRACT Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by persistent synovial inflammation and progressive joint damage. Although ferroptosis has been implicated in RA progression, the role of disulfidptosis and its interaction with ferroptosis remains unclear.
Ting‐Ting Wang +10 more
wiley +1 more source
A Novel HLA Class I Allele, HLA-B*27:310, Identified Using Next-Generation Sequencing. [PDF]
Abdelghany G +3 more
europepmc +1 more source
MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I-ASSOCIATED VACCINE PROTECTION FROM SIMIAN IMMUNODEFICIENCY VIRUS-INFECTED PERIPHERAL-BLOOD CELLS [PDF]
H Niphuis +29 more
core +1 more source
<i>Lactiplantibacillus plantarum</i> BF_15 Confers Protection Against Ulcerative Colitis by Orchestrating Gut Microbiota-Barrier-Immune Triad Homeostasis. [PDF]
Zhang N +8 more
europepmc +1 more source
This review details a three‐stage paradigm shift for tumor‐reactive CD8+ T‐cell identification: decoding transcriptomic states, deciphering clonal functional efficacy, and molecular‐level therapeutic TCR design. Addressing translational hurdles and generative AI “scientific blind spots”—such as missing catch bonds—we present a visionary roadmap.
Chao Yang +4 more
wiley +1 more source
Identification of the Novel HLA-DQB1*06:556 Allele by Next-Generation Sequencing. [PDF]
Du Z, Sudario MEA, Cussen K, Elrefaei M.
europepmc +1 more source
Organoid Coculture Models for Cancer Research and Immunotherapy
This review summarizes organoid coculture platforms, including submerged Matrigel culture, air–liquid interface, microfluidic/organoid‐on‐a‐chip, and 3D bioprinting, for reconstructing the tumor microenvironment to study tumor–stroma/immune crosstalk, evaluate immunotherapies, and enable drug screening.
Zhuo Yang +9 more
wiley +1 more source
Characterisation of a New HLA Allele by Next-Generation Sequencing: HLA-C*06:424Q. [PDF]
Balakrishnan G +4 more
europepmc +1 more source

